HighGravityDataHumana — Apr 30, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000021
Showing in the filing
Diluted earnings per share (EPS) - Adjusted (non-GAAP)
“approximately $16.25”
Period
FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 22
GAAP EPS for FY2025
“approximately $14.68”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Adjusted FY 2025 EPS for FY2025
“approximately $16.25”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $16.25”
Diluted earnings per common share (EPS) GAAP for FY2025
“approximately $14.68 (previously approximately $15.88)”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $14.68”
Total Revenues Consolidated - GAAP for FY2025
“$126 billion to $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“$121 billion to $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of approximately 550,000”
Individual Medicare Advantage annual members… for FY2025
“approximately 550,000”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth within 175,000 to 250,000 range”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results - Insurance segment income f… for FY2025
“$1.5 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.0 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.2 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121.5 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
“We are confident in the growth outlook for value-based care and Medicare Advantage, which will allow us to provide more quality care to a broader group of patients and members. " FY 2025 Earnings Guidance Humana revises its GAAP EPS guidance for the year ending December 31, 2025 (FY 2025) to 'approximately $14.68' from 'approximately $15.88', while affirming its Adjusted EPS guidance of 'approximately $16.25'. Additional FY 2025 guidance points are included on page 12 of this earnings release. Diluted earnings per share FY 2025 Guidance FY 2024 (a) GAAP approximately $14.68 $9.98 Amortization associated with identifiable intangibles 0.49 0.50 Put/call valuation adjustments associated with the company's non-consolidating minority interest investments (b) 1.35 2.45 Value creation initiatives (b) 0.20 2.33 Impact of exit of employer group commercial medical products business — 1.19 Impairment charges — 1.65 Cumulative net tax impact (0.47) (1.89) Adjusted (non-GAAP) – FY 2025 projected (b); FY 2024 reported approximately $16.25 $16.21 Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations. 2 Humana Consolidated Highlights Humana Inc. Summary of Results ($ in millions, except per share amounts) 1Q25 (a) 1Q24 (a) Revenues $32,112 $29,611 Revenues - Adjusted (non-GAAP) $32,112 $29,332 Pretax results $1,691 $1,014 Pretax results - Adjusted (non-GAAP) $1,893 $1,191 EPS $10.30 $6.11 EPS - Adjusted (non-GAAP) $11.58 $7.23 Benefit ratio 87.0 % 88.9 % Operating cos
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.